Autologous correction in patient induced pluripotent stem cell-endothelial cells to identify a novel pathogenic mutation of hereditary hemorrhagic telangiectasia

F Zhou, X Zhao, X Liu, Y Liu, F Ma… - Pulmonary …, 2020 - journals.sagepub.com
Hereditary hemorrhagic telangiectasia is a rare disease with autosomal dominant
inheritance. More than 80% hereditary hemorrhagic telangiectasia patients carry …

Autologous correction in patient induced pluripotent stem cell-endothelial cells to identify a novel pathogenic mutation of hereditary hemorrhagic telangiectasia.

F Zhou, X Zhao, X Liu, Y Liu, F Ma, B Liu… - Pulmonary …, 2020 - europepmc.org
Hereditary hemorrhagic telangiectasia is a rare disease with autosomal dominant
inheritance. More than 80% hereditary hemorrhagic telangiectasia patients carry …

Autologous correction in patient induced pluripotent stem cell-endothelial cells to identify a novel pathogenic mutation of hereditary hemorrhagic telangiectasia

F Zhou, X Zhao, X Liu, Y Liu, F Ma… - Pulmonary …, 2020 - pubmed.ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia is a rare disease with autosomal dominant
inheritance. More than 80% hereditary hemorrhagic telangiectasia patients carry …

[HTML][HTML] Autologous correction in patient induced pluripotent stem cell-endothelial cells to identify a novel pathogenic mutation of hereditary hemorrhagic …

F Zhou, X Zhao, X Liu, Y Liu, F Ma, B Liu… - Pulmonary …, 2020 - ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia is a rare disease with autosomal dominant
inheritance. More than 80% hereditary hemorrhagic telangiectasia patients carry …

Autologous correction in patient induced pluripotent stem cell‐endothelial cells to identify a novel pathogenic mutation of hereditary hemorrhagic telangiectasia

F Zhou, X Zhao, X Liu, Y Liu, F Ma, B Liu… - Pulmonary …, 2020 - Wiley Online Library
Hereditary hemorrhagic telangiectasia is a rare disease with autosomal dominant
inheritance. More than 80% hereditary hemorrhagic telangiectasia patients carry …